Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US

Gynecol Oncol. 2018 May;149(2):318-323. doi: 10.1016/j.ygyno.2018.01.030. Epub 2018 Mar 4.

Abstract

Objective: To identify the trends in incidence of serous fallopian tube, ovarian, and peritoneal epithelial cancers in the United States.

Methods: Data was obtained from United States Cancer Statistics (USCS) from 2001 to 2014. All incidences are per 100,000 women. Analyses were performed using SEER*Stat and Joinpoint regression programs.

Results: Of the 146,470 patients with serous cancers, 9381 (6.4%) were fallopian tube, 121,418 (82.9%) were ovarian, and 15,671 (10.7%) were primary peritoneal. The study period was divided from 2001 to 2005, 2006-2010, and 2011-2014, and there was an increase in fallopian tube incidence from 0.19 to 0.35 to 0.63, with a corresponding decrease in ovarian incidence from 5.31 to 5.08 to 4.86. There was no significant change in peritoneal cancers from 0.64 to 0.69 to 0.62. The age-specific peak incidence of fallopian tube cancer was younger at age 70-74, compared to ovarian and peritoneal cancer at age 75-79. Further, the incidence of serous fallopian tube cancer was highest in Whites at 0.42, compared to Blacks at 0.24, Hispanics at 0.27, and Asians at 0.28.

Conclusion: From 2001 to 2014, the diagnosis of serous fallopian tube cancer increased fourfold with a corresponding decrease in ovarian cancer. The peak incidence of tubal cancer was 70-74years with an increased incidence in Whites.

Keywords: Fallopian tube cancer; Incidence.

MeSH terms

  • Age Factors
  • Aged
  • Carcinoma, Ovarian Epithelial
  • Cystadenocarcinoma, Serous / epidemiology*
  • Cystadenocarcinoma, Serous / pathology
  • Fallopian Tube Neoplasms / epidemiology*
  • Fallopian Tube Neoplasms / pathology
  • Female
  • Humans
  • Incidence
  • Middle Aged
  • Neoplasms, Glandular and Epithelial / epidemiology
  • Neoplasms, Glandular and Epithelial / pathology
  • Ovarian Neoplasms / epidemiology*
  • Ovarian Neoplasms / pathology
  • Peritoneal Neoplasms / epidemiology*
  • Peritoneal Neoplasms / pathology
  • SEER Program
  • United States / epidemiology